Dexamethasone ophthalmic Alternatives Compared
| Dexamethasone ophthalmic | Lotemax (loteprednol) | Sulfacetamide sodium ophthalmic |
|
|---|
| Dexamethasone ophthalmic | Lotemax (loteprednol) | Sulfacetamide sodium ophthalmic |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Uveitis, Conjunctivitis, Macular Edema, Conjunctivitis - Allergic, Diabetic Macular Edema, Iritis, Postoperative Ocular Inflammation, Uveitis - Posterior, Cyclitis, Keratitis... View more |
Prescription only
Prescribed for Conjunctivitis, Keratitis, Iritis, Cyclitis, Postoperative Ocular Inflammation, Rosacea, Seasonal Allergic Conjunctivitis. Lotemax may also be used for purposes not listed in this... View more |
Prescription only
Prescribed for Conjunctivitis, Eye Conditions, Trachoma. Sulfacetamide sodium ophthalmic may also be used for purposes not listed in this medication guide. |
Related suggestions Conjunctivitis
|
|||||||||||||||||||||||
| More about Dexamethasone ophthalmic | More about Lotemax (loteprednol) | More about Sulfacetamide sodium ophthalmic | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Dexamethasone ophthalmic has an average rating of 6.2 out of 10 from a total of 15 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 27% reported a negative effect. |
Lotemax has an average rating of 6.6 out of 10 from a total of 18 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 33% reported a negative effect. |
Sulfacetamide sodium ophthalmic has an average rating of 8.3 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Lotemax side effects |
||||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Dexamethasone ophthalmic prices |
View all Lotemax prices |
|
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| AK-Dex, Decadron Ocumeter, Decadron Phosphate, Ophthalmic, Dexasol, Dextenza, Dexycu, Maxidex, Ozurdex | Other loteprednol brands include: Alrex, Eysuvis, Inveltys, Lotemax SM | AK-Sulf, Bleph-10, Cetamide | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 89 drugs are known to interact with Dexamethasone ophthalmic:
|
A total of 42 drugs are known to interact with Lotemax:
|
A total of 1 drugs are known to interact with Sulfacetamide sodium ophthalmic:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
June 17, 2009 |
April 15, 2011 |
July 21, 1946 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Imuran
Imuran is used for atopic dermatitis, autoimmune hepatitis, chronic active hepatitis, chronic ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
TobraDex
Tobradex (tobramycin, dexamethasone) is used to treat bacterial infections of the eyes. Includes ...
Maxitrol
Maxitrol is used for blepharitis, conjunctivitis, bacterial, keratitis, keratoconjunctivitis, uveitis
Kenalog-40
Kenalog-40 is a long-acting corticosteroid injection for intramuscular (into the muscle) or ...
Cortisone
Cortisone is used for adrenal insufficiency, ankylosing spondylitis, berylliosis, bursitis ...
Atropine ophthalmic
Atropine ophthalmic is used for pupillary dilation, refraction, assessment, uveitis
Adalimumab
Adalimumab is used to treat plaque psoriasis, Crohn's disease, ulcerative colitis, rheumatoid ...
Azathioprine
Azathioprine is used for atopic dermatitis, autoimmune hepatitis, behcet's disease, bullous ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.